The Motley Fool

ANZ Bank (ASX:ANZ) offloads another asset: Should you invest?

The Australia and New Zealand Banking Group (ASX: ANZ) sale has continued today with the banking giant offloading yet another asset.

According to the release, ANZ Group’s New Zealand subsidiary has agreed to sell the OnePath Life NZ business to specialist insurance business Cigna Corporation.

Cigna has agreed to pay NZ$700 million (A$644 million) for the business, which is a slight premium to the embedded value and is expected to generate a gain on sale of approximately NZ$50 million.

The sale is also expected to lift ANZ Group’s Level 1 and Level 2 CET1 ratios by approximately 5 and 15 basis points, respectively.

This won’t mean the end for life insurance in New Zealand for the bank, though. The sale includes a 20-year strategic alliance for Cigna to provide insurance solutions for ANZ bank customers.

Under the agreement, ANZ New Zealand will continue to offer life insurance to its customers, but these insurance policies will be manufactured and managed by Cigna. This is consistent with how the bank currently provides motor vehicle, home, commercial, and travel insurance with its specialist insurance partners.

The sale remains subject to regulatory approval and is expected to complete in FY 2019.

Is ANZ Bank a buy?

While I don’t think that this agreement could be classed as a game-changer, I do like the way the bank is offloading non-core assets and simplifying its business.

In my opinion, the simpler that ANZ Bank becomes, the more attractive it is. So this is certainly another step in the right direction and could make it worth taking a closer look.

While it wouldn’t necessarily be my first pick in the banking sector, it wouldn’t be far behind. I would put it just behind Westpac Banking Corp (ASX: WBC), but ahead of Commonwealth Bank of Australia (ASX: CBA) and National Australia Bank Ltd (ASX: NAB).

Though this top dividend share could be ahead of all the banks right now.

OUR #1 dividend pick to grow your wealth over the new financial year is revealed for FREE here!

Financial year 2018 is here and The Motley Fool’s dividend detective Andrew Page has revealed his must buy dividend share to grow your wealth in 2018.

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor James Mickleboro owns shares of Westpac Banking. The Motley Fool Australia owns shares of National Australia Bank Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more